earnings
confidence high
sentiment neutral
materiality 0.75
ICU Medical Q2 revenue $549.3M (-2% YoY); adjusted EPS $1.88 vs $1.37; narrows FY23 guidance
ICU MEDICAL INC/DE
2023-Q2 EPS reported
-$0.82
revenue$1,117,959,000
- Revenue $549.3M vs $561.0M YoY; GAAP gross margin improved to 35% from 30%.
- GAAP net loss $(9.9)M ($(0.41)/share) vs $(7.5)M ($(0.31)/share) YoY.
- Adjusted diluted EPS $1.88 vs $1.37; adjusted EBITDA $98.1M vs $84.7M.
- Company narrows fiscal year 2023 guidance ranges for revenue and adjusted EPS.